These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11126983)

  • 1. [Adverse reactions of coumarin derivative interactions].
    Wiela-HojeĊ„ska A; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 2000 Sep; 9(51):600-1. PubMed ID: 11126983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug interactions in coumarin anticoagulation].
    Kessler P
    Vnitr Lek; 1999 Aug; 45(8):490-5. PubMed ID: 11045152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential coagulation effects of preoperative complementary and alternative medicines.
    Norred CL; Brinker F
    Altern Ther Health Med; 2001; 7(6):58-67. PubMed ID: 11712472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for bleeding in patients taking coumarins.
    Beyth RJ; Milligan PE; Gage BF
    Curr Hematol Rep; 2002 Sep; 1(1):41-9. PubMed ID: 12901124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The interaction between drugs and oral anticoagulants of the coumarin group].
    Verstraete M
    Sem Hop; 1978 May; 54(13-16):505-8. PubMed ID: 211593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of rats with the Pelargonium sidoides extract EPs 7630 has no effect on blood coagulation parameters or on the pharmacokinetics of warfarin.
    Koch E; Biber A
    Phytomedicine; 2007; 14 Suppl 6():40-5. PubMed ID: 17188479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overanticoagulation associated with combined use of antifungal agents and coumarin anticoagulants.
    Visser LE; Penning-van Beest FJ; Kasbergen AA; De Smet PA; Vulto AG; Hofman A; Stricker BH
    Clin Pharmacol Ther; 2002 Jun; 71(6):496-502. PubMed ID: 12087353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug interactions between coumarin derivatives and antimycotics: also with topical antifungal agents].
    Jessurun NT; van Puijenbroek EP
    Ned Tijdschr Geneeskd; 2013; 157(4):A5317. PubMed ID: 23343733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding complication during coumarin therapy due to amiodarone and azithromycin.
    Bharat V; Mohanty B
    J Assoc Physicians India; 2000 Jul; 48(7):746-7. PubMed ID: 11273517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug interactions with oral anticoagulants of the coumarin type].
    Held H
    Med Monatsschr Pharm; 1980 Feb; 3(2):33-8. PubMed ID: 7464662
    [No Abstract]   [Full Text] [Related]  

  • 11. Asymptomatic excessive coumarin anticoagulation is a risk factor for thrombotic and bleeding complications of oral anticoagulant therapy.
    Poli D; Antonucci E; Gensini GF; Abbate R; Prisco D
    J Thromb Haemost; 2003 Aug; 1(8):1840-1. PubMed ID: 12911603
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacogenetics of coumarin therapy.
    Voora D; McLeod HL; Eby C; Gage BF
    Pharmacogenomics; 2005 Jul; 6(5):503-13. PubMed ID: 16014000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticoagulant action of a new synthetic derivative of 4-hydroxycoumarin and antagonism by synthetic vitamin K1 in the rat].
    Thonnart N; Letist D; Reuse JJ
    C R Seances Soc Biol Fil; 1973; 167(6):1081-5. PubMed ID: 4803162
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of indirect anticoagulants].
    Niedner R; Meyer F
    Z Allgemeinmed; 1974 Nov; 50(32):1471-6. PubMed ID: 4139825
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of drugs on the treatment with oral anticoagulants].
    Loeliger EA
    Ned Tijdschr Geneeskd; 1973 Sep; 117(37):1396-9. PubMed ID: 4787075
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of the beta-receptor blocking agent Visken on the action of coumarin.
    Vinazzer H
    Int J Clin Pharmacol Biopharm; 1975 Dec; 12(4):458-60. PubMed ID: 1351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of anticoagulant therapy.
    Ellison N; Jobes DR; Schwartz AJ
    Int Anesthesiol Clin; 1982; 20(4):121-35. PubMed ID: 6757142
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of the response to oral anticoagulant drugs in man.
    O'Reilly RA; Aggeler PM
    Pharmacol Rev; 1970 Mar; 22(1):35-96. PubMed ID: 4918964
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticoagulant activity of Heraclenin.
    Mishra KC; Sharma RC; Sharma YN; Arora RB
    Indian J Physiol Pharmacol; 1969 Jul; 13(3):153-5. PubMed ID: 5362630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.